TOP

News

Arkis BioSciences selected as the Top Innovator at the 2017 New York Venture Summit
Arkis is honored to have been chosen as the Top Innovator at the 2017 NY Venture Summit, July 18-19th, 2017.  Be sure to visit us in the Big Apple and learn the latest news as Arkis continues to roll out its product portfolio advancing treatments for intracranial hypertension.   
 

Read More

Arkis showcases new Subcutaneous Guidewire at the Los Angeles AANS Conference, April 24-26th at booth 2047.

Arkis BioSciences exhibits new Subcutaneous GuidewireTM, adding to its minimally invasive product line.

Please visit the team now at booth 2047 of the AANS conference in Los Angeles to see the latest additions to the surgical portfolio, and receive an update on our new SureFloTM EVD catheters with Endexo® technology.

Download full press release

Arkis BioSciences Expands Clinical Use Of Its New Minimally Invasive Tunneling Guidewire™ Technology.

Single PassTM shunt workflow enables up to one-third less invasive shunt procedures in hydrocephalus patients.  Please see the full press release, or view our Surgical Innovations product site for more information on our minimally invasive Tunneling GuidewireTM.  

View the full press release

 

Arkis BioSciences exhibits at the 2016 AANS/CNS Joint Section of Pediatric Surgery

Arkis BioSciences will be exhibiting at Booth 210 of the 45th annual AANS/CNS Joint Section of Pediatric Sugery, December 5th-8th 2016 in Orlando, FL.  Our innovative product portfolio of neurosurgical devices including our Tunneling Guidewire, Precision Tunnelerand Subcutaneous Guidewirewill be available for demonstration.  We will also be sharing the company's plans for the launch of Endexo External Ventricular Drainage catheters.  For more information, please visit pedsneurosurgery.org/meetings/current-meeting/.

Read More

Arkis BioSciences exhibits at the 2016 Congress of Neurological Surgeons

Arkis BioSciences will be exhibiting at the 2016 Congress of Neurological Surgeons in San Diego, September 24th - 28th.  Our innovative product portfolio of neurosurgical devices, including our Tunneling Guidewire, will be available for demonstration.  We will also be sharing the company's plans for the launch of Endexo External Ventricular Drainage catheters.  For more information, please visit the 2016 CNS website at www.cns.org/annual-meeting-2016.

Read More

Arkis BioSciences a Bronze Sponsor of the 2016 Nashville Hydrocephalus Association Walk

Come see us at the Nashville Hydrocephalus Association Walk, where people join together to promote a cure for hydrocephalus and to improve the lives of those affected by hydrocephalus!  With only 9 days left, the Nashville HA teams have already raised over $17,000 dollars!  Arkis BioSciences is proud to be a Bronze sponsor of this year's Nashville HA walk.  For more information, visit the Nashville HA Walk team page.

Read More

Arkis BioSciences Closes $3.4M Series-A Investment

Arkis announced this morning the closing of its $3.4 million Series-A investment. The Series-A funding was led by Innova Memphis, followed by Angel Capital Group, the Lighthouse Fund, and other private investors. Arkis’ new financing will accelerate the commercialization of its less-invasive neurosurgical instrumentation and the market release of its in-licensed Endexo® technology. 

View the full press release

Arkis a Bronze sponsor of the 2016 annual HA conference.

Learn more about Arkis’ new innovative treatment devices at this year’s Hydrocephalus Association’s National Conference in Minneapolis, June 16 - 19.  Arkis is a Bronze sponsor of this year’s 14th annual conference and will be exhibiting at booth 8.   To learn more about the Hydrocephalus Association Conference, please visit www.hydrocephalusconference.org.

Read More

Arkis BioSciences exhibits at AANS 2016

Join Arkis this year at booth 4900 of the AANS where we will be presenting Arkis' new Tunneling Guidewire and the company's plans for the launch of Endexo External Ventricular Drainage catheters.  To learn more about the American Academy of Neurological Sciences, visit http://www.aans.org.  

Read More

Arkis featured in Teknovation for launch of Tunneling Guidewire

October 19, 2015: Pershing Yoakley and Associates' Tom Ballard interviews Arkis' CEO, Chad Seaver, on the company's plans for launching its first surgical innovation, the Tunneling GuidewireTM.  

View the full news article

Pages

 

Contact Us

Address:  One Momentum Way, Knoxville, TN 37920   |    Tel: (844) 247-5383 (toll free)

 © Arkis Biosciences   |    Privacy   |    Sitemap

 

 
Go to top